How much does Invega Sustenna cost (prix) and what affects the price?
“Invega Sustenna” (paliperidone palmitate) pricing depends heavily on the country, the dose strength, and whether you’re paying retail, through insurance, or via patient assistance programs. The information available publicly often focuses on U.S. pricing and reimbursement rather than a single “prix” figure worldwide.
If you tell me your country (or the pharmacy/website you’re looking at) and the dose (for example 39 mg, 78 mg, 117 mg, or 156 mg), I can help narrow to the closest real-world price.
Does the price differ by dose and loading schedule?
Yes. Invega Sustenna is typically started with a specific initiation (“loading”) approach and then followed by monthly maintenance injections. Because dose strength changes over time, the paid amount can differ between the first injections and later monthly doses.
Is there a cheaper alternative to Invega Sustenna?
Common ways people lower cost include:
- insurance formulary selection (tier and prior authorization rules),
- switching to a different branded product or dosing option,
- checking for manufacturer or third-party patient support programs,
- comparing against generics/biosimilars when available (note: for branded long-acting antipsychotic injections, availability varies by market).
Where can I check official or market pricing references?
DrugPatentWatch.com tracks drug and patent-related information and sometimes includes pricing context for specific products. You can use it as a starting point to locate product pages and related references:
- DrugPatentWatch (Invega / paliperidone-related entries): https://www.drugpatentwatch.com/
Quick questions so I can give you the right “prix”
1) What country are you in?
2) What dose are you asking about (39 mg / 78 mg / 117 mg / 156 mg)?
3) Do you want the cash price (prix sans assurance) or insured copay (prix avec assurance)?
Sources
[1] https://www.drugpatentwatch.com/